Tate & Lyle PLC
26 September 2001
TATE & LYLE PLC - Trading and Strategic Update
In line with its regular practice, Tate & Lyle issues the following update
prior to meeting with stockbrokers' analysts and entering its closed period
for interim results to 30 September 2001.
Tate & Lyle has longstanding US business activities and some 4,000 US
employees. All of our employees around the world join in offering our deepest
condolences to those who have lost family, friends and colleagues as a result
of the terrible terrorist attacks in the USA on 11 September.
Whilst Tate & Lyle was not directly or materially impacted, we will have a
modest exposure in our captive re-insurance company.
Our overall trading experience to date has not altered since the Chairman's
statement at the Annual General Meeting on 2 August 2001 and remains in line
with our expectations at the beginning of the financial year.
The sale of the Western Sugar Company ('Western') is progressing more slowly
than anticipated. The Rocky Mountain Sugar Growers Co-operative are still
working on securing all of the financing for its acquisition of Western.
Consequently, Tate & Lyle has extended the date for closing to 31 January
2002.
The required waiting period for US competition authorities to raise objections
to the sale of Tate & Lyle North American Sugars Inc., trading as Domino
Sugar, to the investment group led by Alfonso and J. Pepe Fanjul has now
expired without any objection being received. The sale remains on track.
Tate & Lyle and McNeil Nutritionals ('McNeil'), a Johnson & Johnson Company,
announced earlier today the realignment of their sucralose activities into a
new global alliance. The existing licensing agreements, which date back to
1980, will terminate, with Tate & Lyle receiving advance license fees from
McNeil.
$10 million will be paid immediately and a further $10 million will be paid on
each of the first and second anniversaries of the agreement. Under the
agreement, the companies will co-operate closely to further the development of
the sucralose business. Tate & Lyle will act as exclusive broker for sucralose
ingredient sales in certain key markets outside North America.
Enquiries Mark Robinson 020-7626 6525
Chris Fox 020-7626 6525 (Press)
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.